Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study

por Parshina, Ekaterina, Zulkarnaev, Alexey, Tolkach, Alexey, Ivanov, Andrey, Kislyy, Pavel, Gaipov, Abduzhappar
Publicado 2022

Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia

por Parshina, Ekaterina V., Zulkarnaev, Alexey B., Tolkach, Alexey D., Ivanov, Andrey V., Kislyy, Pavel N.
Publicado 2022

Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future

por Noordzij, Marlies, Meijers, Björn, Gansevoort, Ron T, Covic, Adrian, Duivenvoorden, Raphaël, Hilbrands, Luuk B, Hemmelder, Marc H, Jager, Kitty J, Mjoen, Geir, Nistor, Ionut, Parshina, Ekaterina, Pessolano, Giuseppina, Tuglular, Serhan, Vart, Priya, Zanoli, Luca, Franssen, Casper F M
Publicado 2022